Dementia among adults with Down syndrome
Transcript of Dementia among adults with Down syndrome
![Page 1: Dementia among adults with Down syndrome](https://reader033.fdocuments.us/reader033/viewer/2022041718/6253fabeb5be335e5817f04c/html5/thumbnails/1.jpg)
AGING AND END OF LIFE WEBINAR SERIESDementia Among Adults with Down Syndrome: Individual Differences in
Risk and Progression
Wayne Silverman, Ph.D.Department of Behavioral Psychology,
Kennedy Krieger Institute; and Department of Psychiatry and Behavioral Sciences,Johns Hopkins University School of Medicine
![Page 2: Dementia among adults with Down syndrome](https://reader033.fdocuments.us/reader033/viewer/2022041718/6253fabeb5be335e5817f04c/html5/thumbnails/2.jpg)
Webinar Outline
• Overview of Down syndrome (DS)• And the public health significance of aging
• Overview of Alzheimer’s disease (AD)• Connection between DS and AD• Review of individual differences in risk• Review of individual differences in
progression• Summary of gaps in current knowledge
![Page 3: Dementia among adults with Down syndrome](https://reader033.fdocuments.us/reader033/viewer/2022041718/6253fabeb5be335e5817f04c/html5/thumbnails/3.jpg)
Overview of Down Syndrome(Trisomy 21)
• The most prevalent genetic cause of intellectual disability.
• Results from the presence of an extra (third) copy of chromosome 21– Usually an entire copy, but variants can occur
• Partial trisomy• mosaicism
![Page 4: Dementia among adults with Down syndrome](https://reader033.fdocuments.us/reader033/viewer/2022041718/6253fabeb5be335e5817f04c/html5/thumbnails/4.jpg)
![Page 5: Dementia among adults with Down syndrome](https://reader033.fdocuments.us/reader033/viewer/2022041718/6253fabeb5be335e5817f04c/html5/thumbnails/5.jpg)
Overview of Down Syndrome(Trisomy 21)
• The most prevalent genetic cause of intellectual disability– Incidence of approximately 1 in 740 live births.– Risk increases with maternal age, but most
affected births occur for “younger” mothers.– Characteristic phenotype.
![Page 6: Dementia among adults with Down syndrome](https://reader033.fdocuments.us/reader033/viewer/2022041718/6253fabeb5be335e5817f04c/html5/thumbnails/6.jpg)
![Page 7: Dementia among adults with Down syndrome](https://reader033.fdocuments.us/reader033/viewer/2022041718/6253fabeb5be335e5817f04c/html5/thumbnails/7.jpg)
Median Age at Death of Persons with Down Syndrome:U.S. White Population - 1968 to 1997
From Morbidity & Mortality Weekly Report, 2001Vol. 50, 463-465.
1970 1975 1980 1985 1990 1995
YEAR
0
10
20
30
40
50
60
Age at D
eath (Years)
![Page 8: Dementia among adults with Down syndrome](https://reader033.fdocuments.us/reader033/viewer/2022041718/6253fabeb5be335e5817f04c/html5/thumbnails/8.jpg)
We now need to support a rapidly expanding older population with DS.
![Page 9: Dementia among adults with Down syndrome](https://reader033.fdocuments.us/reader033/viewer/2022041718/6253fabeb5be335e5817f04c/html5/thumbnails/9.jpg)
Characteristics of Atypical Aging Associatedwith Down Syndrome
• premature changes in skin and hair greying• early menopause• increased frequency of senile cataracts• increased frequency of hearing loss• age-related increase in hypothyroidism• age-related increase in seizures• Dramatically increased risk of AD• Reduced life expectancy
![Page 10: Dementia among adults with Down syndrome](https://reader033.fdocuments.us/reader033/viewer/2022041718/6253fabeb5be335e5817f04c/html5/thumbnails/10.jpg)
Not All Bad News for Aging with Down Syndrome: Medical Conditions with Low Risk
• Solid Tumor Cancers
• Type 2 Diabetes (RR=0.4, despite prevalent obesity)
• Cardiovascular and cerebrovascular disease– Heart Disease (ischemic heart disease) (RR=0.7)
– Hypertension (RR=0.1)
– Stroke
![Page 11: Dementia among adults with Down syndrome](https://reader033.fdocuments.us/reader033/viewer/2022041718/6253fabeb5be335e5817f04c/html5/thumbnails/11.jpg)
“Public Health” Importance of Understanding Dementia among Adults
with Down Syndrome
Projected “elderly” U.S. population with DS
200,000 over 55 (based upon current incidence and survival rates), and
85,000 likely to develop AD
Potential annual cost of care > $10 billion.
![Page 12: Dementia among adults with Down syndrome](https://reader033.fdocuments.us/reader033/viewer/2022041718/6253fabeb5be335e5817f04c/html5/thumbnails/12.jpg)
![Page 13: Dementia among adults with Down syndrome](https://reader033.fdocuments.us/reader033/viewer/2022041718/6253fabeb5be335e5817f04c/html5/thumbnails/13.jpg)
Overview of Alzheimer’s disease
• The most prevalent cause of dementia in old age.
• Cause remains unknown• Risk increases substantially after age 65-70
– Except for rare cases with genetic predisposition• Has a distinctive profile
– Slowly progressing clinical dementia– Broad spectrum of neuropathology
![Page 14: Dementia among adults with Down syndrome](https://reader033.fdocuments.us/reader033/viewer/2022041718/6253fabeb5be335e5817f04c/html5/thumbnails/14.jpg)
Alzheimer’s Disease: Most Common Cause of Old-Age Associated Dementia
AD55%
Mixed AD15%
Vascular22%
Other8%
![Page 15: Dementia among adults with Down syndrome](https://reader033.fdocuments.us/reader033/viewer/2022041718/6253fabeb5be335e5817f04c/html5/thumbnails/15.jpg)
DSM-IV Definition of Dementia
Development of multiple cognitive deficits…,
Characterized by a substantial decline in abilities associated with functional impairment.
Nonspecific with regard to underlying cause.
![Page 16: Dementia among adults with Down syndrome](https://reader033.fdocuments.us/reader033/viewer/2022041718/6253fabeb5be335e5817f04c/html5/thumbnails/16.jpg)
Complication
Lots of other illnesses or conditions can cause clinical dementia, some not even related to CNS function (e.g., untreated hypothyroidism, HIV, TBI, drug toxicity, poorly recognized systemic illness).
This complicates diagnosis, practice, planning and research, but it’s topic for another day.
![Page 17: Dementia among adults with Down syndrome](https://reader033.fdocuments.us/reader033/viewer/2022041718/6253fabeb5be335e5817f04c/html5/thumbnails/17.jpg)
Progression from "Normal Aging" to Advanced Dementia Due to Alzheimer's Disease
Transition Transition
Transition
"Normal Aging" MCI Dementia Late Stage Dementia
AGE
CA
PA
BILITIE
S
![Page 18: Dementia among adults with Down syndrome](https://reader033.fdocuments.us/reader033/viewer/2022041718/6253fabeb5be335e5817f04c/html5/thumbnails/18.jpg)
Duration of decline for Adults with Alzheimer’s Disease Without ID
No Decline
“Normal Aging”
Mild Cognitive Impairment
Moderate Cognitive Impairment
Early Dementia
Severe Dementia
Profound Dementia
Death
Adapted From: Reisberg, B. (1986). Geriatrics,41, 430-446.
15+
7
2
1.5
2.5
6
Years
![Page 19: Dementia among adults with Down syndrome](https://reader033.fdocuments.us/reader033/viewer/2022041718/6253fabeb5be335e5817f04c/html5/thumbnails/19.jpg)
Neuropathological Characteristics of AD(“Gold standard” for diagnosis)
• Amyloid plaque deposits (substantial numbers)
• Neurofibrillary pathology
• Neuron loss and gross atrophy
• Distinct topographic progression
• Etc.
![Page 20: Dementia among adults with Down syndrome](https://reader033.fdocuments.us/reader033/viewer/2022041718/6253fabeb5be335e5817f04c/html5/thumbnails/20.jpg)
Neuritic Plaque
![Page 21: Dementia among adults with Down syndrome](https://reader033.fdocuments.us/reader033/viewer/2022041718/6253fabeb5be335e5817f04c/html5/thumbnails/21.jpg)
Neurofibrillary Tangles
![Page 22: Dementia among adults with Down syndrome](https://reader033.fdocuments.us/reader033/viewer/2022041718/6253fabeb5be335e5817f04c/html5/thumbnails/22.jpg)
Alzheimer’s Disease AssociatedGross Pathology
![Page 23: Dementia among adults with Down syndrome](https://reader033.fdocuments.us/reader033/viewer/2022041718/6253fabeb5be335e5817f04c/html5/thumbnails/23.jpg)
![Page 24: Dementia among adults with Down syndrome](https://reader033.fdocuments.us/reader033/viewer/2022041718/6253fabeb5be335e5817f04c/html5/thumbnails/24.jpg)
Down Syndrome and “Alzheimer’s Disease”
Reports of dementia in older adults with Down syndrome date back to the late 1800’s -
Even before Alzheimer described AD.
However, early reports were only of academic interest because very few individuals lived long enough to be at risk. It has only been since the 1980’s that the public health significance of this association was appreciated and relevant issues began to attract “serious” attention.
![Page 25: Dementia among adults with Down syndrome](https://reader033.fdocuments.us/reader033/viewer/2022041718/6253fabeb5be335e5817f04c/html5/thumbnails/25.jpg)
Why is there an association between AD and DS?
![Page 26: Dementia among adults with Down syndrome](https://reader033.fdocuments.us/reader033/viewer/2022041718/6253fabeb5be335e5817f04c/html5/thumbnails/26.jpg)
AD Cause: Amyloid Cascade Hypothesis
β-amyloid deposition causes AD by triggering a complex pathological cascade that leads to the broad spectrum of neuropathological changes seen in AD together with clinical dementia.
β-amyloid is formed from a larger protein needed for normal cell function, called amyloid precursor protein (APP).
![Page 27: Dementia among adults with Down syndrome](https://reader033.fdocuments.us/reader033/viewer/2022041718/6253fabeb5be335e5817f04c/html5/thumbnails/27.jpg)
Down syndrome and APP
• The gene coding for APP is on chromosome 21
• Individuals with DS have 3 copies of this gene and produce excess APP
• Over many years, this excess APP leads to β-amyloid plaque formation and eventual AD
![Page 28: Dementia among adults with Down syndrome](https://reader033.fdocuments.us/reader033/viewer/2022041718/6253fabeb5be335e5817f04c/html5/thumbnails/28.jpg)
DS and AD: Neuropathological Criteria
• Virtually all individuals with DS have amyloid deposits in their brains consistent with a diagnosis of AD by the time they are 35-40 years of age.
![Page 29: Dementia among adults with Down syndrome](https://reader033.fdocuments.us/reader033/viewer/2022041718/6253fabeb5be335e5817f04c/html5/thumbnails/29.jpg)
DS (Age 65): Parahippocampus immunostained to show βA plaques
![Page 30: Dementia among adults with Down syndrome](https://reader033.fdocuments.us/reader033/viewer/2022041718/6253fabeb5be335e5817f04c/html5/thumbnails/30.jpg)
Parahippocampus stained to show plaques:65 year old with DS on left,78 year old with advanced AD on right
![Page 31: Dementia among adults with Down syndrome](https://reader033.fdocuments.us/reader033/viewer/2022041718/6253fabeb5be335e5817f04c/html5/thumbnails/31.jpg)
DS Age 65: Parahippocampus stained with Tau1 to show neurofibrillary pathology
![Page 32: Dementia among adults with Down syndrome](https://reader033.fdocuments.us/reader033/viewer/2022041718/6253fabeb5be335e5817f04c/html5/thumbnails/32.jpg)
DS and AD: Neuropathological Criteria
• Virtually all individuals with DS have amyloid deposits in their brains consistent with a diagnosis of AD by the time they are 35-40 years of age.
• What about dementia?
![Page 33: Dementia among adults with Down syndrome](https://reader033.fdocuments.us/reader033/viewer/2022041718/6253fabeb5be335e5817f04c/html5/thumbnails/33.jpg)
Complication
It is difficult to recognize dementia for individuals having preexisting cognitive impairments that vary widely in their severity. There are no “standard” methods for assessment or diagnostic criteria. Nevertheless, we can:
– Document substantial decline from previous status and rely on these findings to inform clinical judgment.
![Page 34: Dementia among adults with Down syndrome](https://reader033.fdocuments.us/reader033/viewer/2022041718/6253fabeb5be335e5817f04c/html5/thumbnails/34.jpg)
Well Defined Clinical Characteristics of AD can be Useful in Recognizing
Transitions in Adults with DS
• Progressive Decline in – Memory and Cognition– Motor Function– Activities of Daily Living– Changes in Mood and Behavior
• Severity of deficits increase dramatically over extended time
![Page 35: Dementia among adults with Down syndrome](https://reader033.fdocuments.us/reader033/viewer/2022041718/6253fabeb5be335e5817f04c/html5/thumbnails/35.jpg)
Our Consensus Dementia RatingsOverall classification established every 14-18 months
based upon a comprehensive evaluations.
Not demented Stable or age-related changesQuestionable Some declines or concerns; unlikely
due to aging, per seWith complications Substantial declines that may be due
to “other” conditionPossible dementia Substantial declines of late onsetDefinite dementia Substantial declines of extended
durationUnknown status Circumstances prevent determination
![Page 36: Dementia among adults with Down syndrome](https://reader033.fdocuments.us/reader033/viewer/2022041718/6253fabeb5be335e5817f04c/html5/thumbnails/36.jpg)
00.10.20.30.40.50.60.70.80.9
1
40 50 60 70AGE
Cum
ulat
ive
Inci
denc
e
Down Syndrome
Cumulative Incidence of Dementia/AD in Down Syndrome
![Page 37: Dementia among adults with Down syndrome](https://reader033.fdocuments.us/reader033/viewer/2022041718/6253fabeb5be335e5817f04c/html5/thumbnails/37.jpg)
Cumulative Incidence of Dementia/AD in Adults with Down Syndrome (Yellow), the Overall
Population (Red), and Other ID (Green)
0102030405060708090
100
40 50 60 70 80 90
Age
Cu
mu
lati
ve I
nci
den
ce
![Page 38: Dementia among adults with Down syndrome](https://reader033.fdocuments.us/reader033/viewer/2022041718/6253fabeb5be335e5817f04c/html5/thumbnails/38.jpg)
Alzheimer’s Disease and Down Syndrome:The Big Picture
Increased risk and younger age of onset;AD neuropathology present from 30s;Incidence of dementia increases in 50s;
Substantial individual differences.
![Page 39: Dementia among adults with Down syndrome](https://reader033.fdocuments.us/reader033/viewer/2022041718/6253fabeb5be335e5817f04c/html5/thumbnails/39.jpg)
DS and AD:Examining Individual Differences in Risk
![Page 40: Dementia among adults with Down syndrome](https://reader033.fdocuments.us/reader033/viewer/2022041718/6253fabeb5be335e5817f04c/html5/thumbnails/40.jpg)
DS and AD: Apolipoprotein E genotype: (Schupf et al, 1996)
• Gene on chromosome 19;• Three common alleles -- e2, e3, e4
– One allele is inherited from each parent• e3 is most common;
• e2 is associated with decreased risk for AD;
• e4 is associated with increased risk.
![Page 41: Dementia among adults with Down syndrome](https://reader033.fdocuments.us/reader033/viewer/2022041718/6253fabeb5be335e5817f04c/html5/thumbnails/41.jpg)
0
0.2
0.4
0.6
0.8
1
45 50 55 60 65
Cum
ulat
ive
Inci
denc
e (%
)
AGE
Early onset of AD in those with the e4 allele (Red) and delay in onset with the e2 allele
(Green).
Schupf et al., 1996
![Page 42: Dementia among adults with Down syndrome](https://reader033.fdocuments.us/reader033/viewer/2022041718/6253fabeb5be335e5817f04c/html5/thumbnails/42.jpg)
Down syndrome and amyloid beta-peptides
• Aβ 1-42 is the earliest form of Aβ deposited
– Aβ 1-42 can be observed in diffuse plaques as early as 12 years of age
– even in older DS (> 50 years), Aβ 1-42 is more abundant in plaques than Aβ (1-40)
![Page 43: Dementia among adults with Down syndrome](https://reader033.fdocuments.us/reader033/viewer/2022041718/6253fabeb5be335e5817f04c/html5/thumbnails/43.jpg)
Time since baseline (years)
6543210
Cum
ulativ
e In
ciden
ce o
f AD
.6
.5
.4
.3
.2
.1
0.0
Risk of Dementia/AD by tertiles of Aβ 1-42 in blood: Incident cases
LowestMiddleHighest
Schupf et al., 2007
![Page 44: Dementia among adults with Down syndrome](https://reader033.fdocuments.us/reader033/viewer/2022041718/6253fabeb5be335e5817f04c/html5/thumbnails/44.jpg)
Can Aβ 1-42 be used as a biomarker to inform diagnosis?
![Page 45: Dementia among adults with Down syndrome](https://reader033.fdocuments.us/reader033/viewer/2022041718/6253fabeb5be335e5817f04c/html5/thumbnails/45.jpg)
Abeta 1-40 (pg/ml)
4003002001000
Abet
a 1-
42 (p
g/m
l)50
40
30
20
10
0
Aβ1-42 and Aβ1-40 for adults with (red) and without dementia
![Page 46: Dementia among adults with Down syndrome](https://reader033.fdocuments.us/reader033/viewer/2022041718/6253fabeb5be335e5817f04c/html5/thumbnails/46.jpg)
Estrogen and Alzheimer’s disease (Schupf, et al.)
• Estrogen: • Promotes the growth of cholinergic neurons and
regulates the metabolism of APP to protect against Aβ deposition
• Seems to affect cognition in post-menopausal women
• Higher levels may delay or prevent the onset of AD, although large HRT trials have generated conflicting results.
![Page 47: Dementia among adults with Down syndrome](https://reader033.fdocuments.us/reader033/viewer/2022041718/6253fabeb5be335e5817f04c/html5/thumbnails/47.jpg)
Menopause
• Menopause results in lowered bioavailability of estrogen
• Women with Down syndrome have early menopause – Median age of 46 (versus 51 for general
population) with some variation
![Page 48: Dementia among adults with Down syndrome](https://reader033.fdocuments.us/reader033/viewer/2022041718/6253fabeb5be335e5817f04c/html5/thumbnails/48.jpg)
r =.57
Age at Menopause
5248444036
Age
at O
nset
of A
D
60
55
50
45
40
r=.54
Onset of dementia by age at menopause for women with DS
![Page 49: Dementia among adults with Down syndrome](https://reader033.fdocuments.us/reader033/viewer/2022041718/6253fabeb5be335e5817f04c/html5/thumbnails/49.jpg)
AGE
5854504642
Cum
ulativ
e In
ciden
ce o
f AD
.8
.6
.4
.2
0.0
Menopause onset < 46 yrs
Menopause onset > 46 yrs
Incidence of AD by Age at Menopause in Women with DS
Schupf et al. 2003
![Page 50: Dementia among adults with Down syndrome](https://reader033.fdocuments.us/reader033/viewer/2022041718/6253fabeb5be335e5817f04c/html5/thumbnails/50.jpg)
AGE
656055504540
Cum
ulat
ive
Inci
denc
e of
AD
.6
.5
.4
.3
.2
.1
0.0
Low bioavailable E2
High Bioavailable E2
Incidence of Dementia Related to Estrogen Bioavailability
![Page 51: Dementia among adults with Down syndrome](https://reader033.fdocuments.us/reader033/viewer/2022041718/6253fabeb5be335e5817f04c/html5/thumbnails/51.jpg)
Cholesterol and AD (Zigman, et al.)
• Both the generation and clearance of Aβ are regulated by cholesterol.
• Elevated cholesterol levels increase risk in most animal models of AD.
• In the general population high total cholesterol levels during midlife increase risk of AD (a little), although findings have been inconsistent.
• What about for DS?
![Page 52: Dementia among adults with Down syndrome](https://reader033.fdocuments.us/reader033/viewer/2022041718/6253fabeb5be335e5817f04c/html5/thumbnails/52.jpg)
7.006.005.004.003.002.001.000.00
Time Since Baseline (in years)
0.8
0.6
0.4
0.2
0.0
Cum
ulat
ive H
azar
d High - censoredDesirable - censoredHighDesirable
TC Category
DS and AD: Cumulative incidence and cholesterol level
HR= 2.6 (1.2-6.1)
Zigman et al. 2006
![Page 53: Dementia among adults with Down syndrome](https://reader033.fdocuments.us/reader033/viewer/2022041718/6253fabeb5be335e5817f04c/html5/thumbnails/53.jpg)
8.007.006.005.004.003.002.001.000.00Time Since Baseline (in years)
0.5
0.4
0.3
0.2
0.1
0.0
Cum
ulat
ive H
azar
d
Yes - censoredNo - censoredYesNoStatin Use
DS and AD:High cholesterol and statin use
HR= 0.4 (0.2-0.99)
![Page 54: Dementia among adults with Down syndrome](https://reader033.fdocuments.us/reader033/viewer/2022041718/6253fabeb5be335e5817f04c/html5/thumbnails/54.jpg)
Conclusions
• Individual differences in risk for AD are evident among adults with DS, and we are beginning to understand contributing factors.
• There may be targets for intervention, and there is a pressing need for well controlled clinical trials specifically for adults with DS.
![Page 55: Dementia among adults with Down syndrome](https://reader033.fdocuments.us/reader033/viewer/2022041718/6253fabeb5be335e5817f04c/html5/thumbnails/55.jpg)
![Page 56: Dementia among adults with Down syndrome](https://reader033.fdocuments.us/reader033/viewer/2022041718/6253fabeb5be335e5817f04c/html5/thumbnails/56.jpg)
DS and AD: Individual differences in rate of
progression
![Page 57: Dementia among adults with Down syndrome](https://reader033.fdocuments.us/reader033/viewer/2022041718/6253fabeb5be335e5817f04c/html5/thumbnails/57.jpg)
How Rapidly does Dementia Advance in Adults with DS, Gradually or Abruptly (“like
falling off a cliff”)? How much does the pattern vary across individuals?
We looked at 88 adults with dementia to see how long it took from diagnosis until they:
(a) developed seizures,(b) moved to a more service-intensive program of supports, or
(c) died.
![Page 58: Dementia among adults with Down syndrome](https://reader033.fdocuments.us/reader033/viewer/2022041718/6253fabeb5be335e5817f04c/html5/thumbnails/58.jpg)
Qualification
• Clinicians vary in their diagnostic practices. This affects the precision of our estimates of time intervals.
• We’re working on something better, but for now this is what I have.
![Page 59: Dementia among adults with Down syndrome](https://reader033.fdocuments.us/reader033/viewer/2022041718/6253fabeb5be335e5817f04c/html5/thumbnails/59.jpg)
0 1 2 3 4 5
Years
0.0
0.2
0.4
0.6
0.8
1.0
Duration Between the Earliest Symptoms of Dementia and Clinical Diagnosis for Adults with Down Syndrome
![Page 60: Dementia among adults with Down syndrome](https://reader033.fdocuments.us/reader033/viewer/2022041718/6253fabeb5be335e5817f04c/html5/thumbnails/60.jpg)
How quickly do seizures develop following diagnosis of AD?
• Of our 88 adults with Down syndrome who were demented:– 5 had a history of seizures from before the age of
40;– 44 (52%) developed seizures following onset of
dementia;– 39 (44%) have, as yet, no history of seizures.
![Page 61: Dementia among adults with Down syndrome](https://reader033.fdocuments.us/reader033/viewer/2022041718/6253fabeb5be335e5817f04c/html5/thumbnails/61.jpg)
0 2 4 6 8 10
Years
0.0
0.2
0.4
0.6
0.8
1.0
Development of Seizures Following A Diagnosis of Dementia in Adults with Down Syndrome
![Page 62: Dementia among adults with Down syndrome](https://reader033.fdocuments.us/reader033/viewer/2022041718/6253fabeb5be335e5817f04c/html5/thumbnails/62.jpg)
How long will it be before a move will have to be made to a more service intensive
program?
• Of the 88 adults with Down syndrome and dementia, 8 were in nursing homes the first time we saw them:– 20 individuals moved to a more service
intensive program following the onset of dementia.
![Page 63: Dementia among adults with Down syndrome](https://reader033.fdocuments.us/reader033/viewer/2022041718/6253fabeb5be335e5817f04c/html5/thumbnails/63.jpg)
0 1 2 3 4 5
Years
0.0
0.2
0.4
0.6
0.8
1.0
Movement to a More Intensive Program of Services Following a Diagnosis of Dementia for Adults with Down Syndrome
![Page 64: Dementia among adults with Down syndrome](https://reader033.fdocuments.us/reader033/viewer/2022041718/6253fabeb5be335e5817f04c/html5/thumbnails/64.jpg)
How does Alzheimer’s Disease Affect Survival of Adults with Down Syndrome?
45 adults with Down syndrome and dementia have died since the beginning of our study and the time of this analysis. As expected, dementia is associated with increased mortality risk, reducing survival by 5-10 years.
What is life expectancy following diagnosis of dementia, and is it comparable to what we see in the general population?
![Page 65: Dementia among adults with Down syndrome](https://reader033.fdocuments.us/reader033/viewer/2022041718/6253fabeb5be335e5817f04c/html5/thumbnails/65.jpg)
0 2 4 6 8 10 12 14 16
Years
0.0
0.2
0.4
0.6
0.8
1.0
Years of Survival Following a Diagnosis of Dementia in Adults w Down Syndrome
![Page 66: Dementia among adults with Down syndrome](https://reader033.fdocuments.us/reader033/viewer/2022041718/6253fabeb5be335e5817f04c/html5/thumbnails/66.jpg)
Non MR data simulate Stern, et al. (1997). JAMA, 277, 806-812.
![Page 67: Dementia among adults with Down syndrome](https://reader033.fdocuments.us/reader033/viewer/2022041718/6253fabeb5be335e5817f04c/html5/thumbnails/67.jpg)
Factors NOT Strongly Related toRate of Progression
• Age at diagnosis of AD• ApoE genotype• Gender• Severity of ID
• Note: These results are based on preliminary analyses of relatively small subsamples and must be interpreted cautiously.
![Page 68: Dementia among adults with Down syndrome](https://reader033.fdocuments.us/reader033/viewer/2022041718/6253fabeb5be335e5817f04c/html5/thumbnails/68.jpg)
Conclusions
Alzheimer’s disease has devastating consequences for any affected individual. For adults with DS, rate of progression seems slightly increased, but, nevertheless:
• Mortality risk is low during the first few years following diagnosis.
• Rate of progression varies substantially among individuals.
• Anecdotal reports of adults with Down syndrome “falling off a cliff” reflect unusual cases.
– In such cases, severe symptoms may be due to some additional, perhaps treatable problem.
![Page 69: Dementia among adults with Down syndrome](https://reader033.fdocuments.us/reader033/viewer/2022041718/6253fabeb5be335e5817f04c/html5/thumbnails/69.jpg)
![Page 70: Dementia among adults with Down syndrome](https://reader033.fdocuments.us/reader033/viewer/2022041718/6253fabeb5be335e5817f04c/html5/thumbnails/70.jpg)
DS and AD: Gaps in Knowledge
• There are no gold standard methods for evaluating symptoms of dementia.
• Nor are there criteria for defining dementia quantitatively or clinically.
• Standards for diagnosis in early stages of AD are needed, as are operational definitions of “mild cognitive impairment - MCI.”
![Page 71: Dementia among adults with Down syndrome](https://reader033.fdocuments.us/reader033/viewer/2022041718/6253fabeb5be335e5817f04c/html5/thumbnails/71.jpg)
ParadoxIf all adults with DS in their mid-30s or older have
key neuropathological hallmarks of AD, and
If most of these adults have no dementia,
Then the current “gold standard” for diagnosis of AD is meaningless for this population.
We need to develop valid diagnostic standards, and we need to determine what specific neuropathology actually causes dementia.
![Page 72: Dementia among adults with Down syndrome](https://reader033.fdocuments.us/reader033/viewer/2022041718/6253fabeb5be335e5817f04c/html5/thumbnails/72.jpg)
Gaps in Knowledge
• We need to understand why dementia occurs well after substantial neuropathology is present.
• We need to understand why some individuals with Down syndrome are far more vulnerable than others.
![Page 73: Dementia among adults with Down syndrome](https://reader033.fdocuments.us/reader033/viewer/2022041718/6253fabeb5be335e5817f04c/html5/thumbnails/73.jpg)
Gap in Knowledge
All current knowledge of “old age” reflect experiences of adults with DS born when they weren’t expected to survive past childhood. Are they therefore the fittest among their generation?
We need to learn how to anticipate cohort effects that could be very substantial.
![Page 74: Dementia among adults with Down syndrome](https://reader033.fdocuments.us/reader033/viewer/2022041718/6253fabeb5be335e5817f04c/html5/thumbnails/74.jpg)
Huge Gap in Knowledge
We need to discover how to treat and prevent AD (as well as other old-age associated conditions causing dementia).
![Page 75: Dementia among adults with Down syndrome](https://reader033.fdocuments.us/reader033/viewer/2022041718/6253fabeb5be335e5817f04c/html5/thumbnails/75.jpg)
Some resources that would be very helpful for future research
• Registry of possible research participants– Consensus core dataset
• Tissue repository– Clinically well characterized cases– Variety of tissues– System to encourage postmortem organ donations
• Support of collaborations across institutions.
![Page 76: Dementia among adults with Down syndrome](https://reader033.fdocuments.us/reader033/viewer/2022041718/6253fabeb5be335e5817f04c/html5/thumbnails/76.jpg)
My Co-Investigators
IBR: W. Zigman, D. Devenny, S. Krinsky-McHale, S.Y. Kim, P. Kittler, P. Mehta, E. Jenkins, W.T. Brown, M. Vilenov, C. Dobkin, N. Zhong, Y.W. Hwang, K. Dowjat, W. Kaczmarski, C.X. Gong, T. Adayev, M. Barua, H. Imaki, J. Wegiel, I. Kuchna, K. Nowicki.
Columbia: N. Schupf, B. Tycko, R. Mayeux, D. Warburton, Y. Stern, J. Kline, M. Ferin, S. Winsten, A. Greenacre.
NYU: T. Wisniewski, B. Reisberg.
Independent Statistician: L. Muenz.
KKI/JHUSOM: W. Silverman, M. Kraut.
![Page 77: Dementia among adults with Down syndrome](https://reader033.fdocuments.us/reader033/viewer/2022041718/6253fabeb5be335e5817f04c/html5/thumbnails/77.jpg)